Home
Suven Life Sciences Ltd Board of Directors
Board of Directors at Suven Life Sciences Ltd
Independent Director
Independent Director
Non Executive Director
Company Sec. & Compli. Officer
Whole-time Director
Key Highlights
- Venkateswarlu Jasti continues to serve as the Chairman & CEO in 2024, maintaining the same position as in the previous year.
- Sudha Rani Jasti continues to serve as the Whole-time Director in 2024, maintaining the same position as in the previous year.
- Seyed E Hasnain joins the board as Non Executive Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Santanu Mukherjee continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
- J A S Padmaja joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.

Suven Life Sciences Ltd
NSE: SUVEN
Share Price
Last Ten Days Market Price
Date | |
---|---|
11 Apr 2025 | 122.4 |
09 Apr 2025 | 119.55 |
08 Apr 2025 | 121.7 |
07 Apr 2025 | 118.85 |
04 Apr 2025 | 128.85 |
03 Apr 2025 | 131.25 |
02 Apr 2025 | 125.9 |
01 Apr 2025 | 121.95 |
28 Mar 2025 | 113.4 |
27 Mar 2025 | 114.85 |
Company Fundamentals for Suven Life Sciences Ltd
Market Cap
2,669 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
13.9
Day’s High
125.25
Day’s Low
121.45
DTE
0.0
ROE
-75.8
52 Week High
169.0
52 Week Low
83.27
ROCE
-76.1
Market Price of Suven Life Sciences Ltd
1M
1Y
3Y
5Y
Suven Life Sciences Ltd News Hub
Indices trade with major losses; media shares under pressure
The headline equity benchmarks traded with deep cuts in the mid-afternoon trade. The decline was dri
Read more
05 Aug 24
Suven Life Sciences reports consolidated net loss of Rs 28.04 crore in the June 2024 quarter
Net Loss of Suven Life Sciences reported to Rs 28.04 crore in the quarter ended June 2024 as against
Read more
05 Aug 24
Suven Life hits lower circuit as Q1 net loss widens to Rs 28 cr
Consolidated net sales slipped 73.42% year on year (YoY) to Rs 1.01 crore in the quarter ended 30 Ju
Read more
05 Aug 24
Suven Life Sciences announces board meeting date
Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 29 October 2024.
Read more
21 Oct 24